查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年製藥機器人市場預測：按產品、應用、最終用戶和地區進行全球分析
市場調查報告書
商品編碼
1383479

2030 年製藥機器人市場預測：按產品、應用、最終用戶和地區進行全球分析

Pharmaceutical Robots Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球製藥機器人市場規模為 2.0425 億美元，預計到 2030 年將達到 5.4996 億美元，預測期內年複合成長率為 15.2%。

製藥機器人市場是醫療保健和製藥行業的一個子集，重點是機器人技術和自動化在各種製藥流程和應用中的使用。這些專用機器人旨在執行藥品製造、藥物研發、樣品處理、實驗室自動化、包裝等。製藥機器人透過提供精確度、一致性、效率並降低人為錯誤和污染的風險來提高藥品的品質和安全性。

根據CNBC公佈的資料，2020年6月，美國累積失業率從2020年4月的14.7%下降至2020年5月的13.3%。同時，2020年1月至2020年4月製造業整體就業率以19.1%的比例下降，面臨急劇收縮，導致30%的製造商表示正在尋找新員工。

對無菌環境的需求不斷增加

無菌條件在藥品生產中至關重要，特別是在生技藥品的生產中，以防止污染並確保藥品的安全性和有效性。製藥機器人專門設計用於在無塵室和無菌環境中工作，使其成為實現高無菌標準的寶貴資產。隨著製藥業專注於生物製藥和無菌加工，對能夠在無菌條件下運作的製藥機器人的需求不斷增加。這些機器人不僅提高了藥品的品質和安全性，還有助於最佳化無菌製造流程，從而成為製藥機器人市場成長的關鍵驅動力。

初始成本高

取得和實施機器人系統可能需要大量的初期成本，包括購買機器人本身、將其整合到當前的製藥流程中以及培訓操作和維護設備的工人。對於資源有限的中小型製藥公司、研究機構和新興企業來說，這些成本可能特別高。對製藥機器人的投資需要嚴格的財務規劃和合理性，以權衡提高效率、準確性和生產力的潛在長期利益與直接成本。有很多。然而，雖然這項技術可能會帶來長期的成本節約並提高產品質量，但最初的成本障礙阻礙了機器人自動化的採用，特別是當有更經濟的替代方案可用時，一些公司可能會阻止這種做法。

藥物開發的成長

製藥部門不斷擴張，研發投資不斷增加，特別是在生物技術和個體化治療等領域。製藥機器人透過加速藥物研發和開發過程，在這個不斷變化的環境中發揮關鍵作用。隨著滲透療法和治療方法需求的增加，製藥公司擴大轉向機器人自動化，以加快其藥物開發平臺。製藥機器人市場正在響應這一需求，透過提供複雜的解決方案來滿足業界對更快、更有效率的藥物開發程序的渴望，從而將自己確立為這一不斷變化的形勢的驅動力。

技術故障的風險

製藥公司使用機器人來實現藥物配方、樣本處理和實驗室測試等關鍵流程的自動化。儘管機器人自動化有許多好處，但它也存在技術錯誤和故障，這可能會為製藥業務帶來嚴重的問題和風險。機器人系統的技術缺陷可能會導致錯誤、故障或有價值的醫療用品損壞。由於機器人技術的複雜性，識別和解決問題是一個專門且耗時的過程，可能會導致代價高昂的停機時間並降低生產率。

COVID-19 的影響：

疫情也暴露了全球供應鏈的缺陷，並導致機器人系統的採購和維護出現延誤。對此，產業不斷發展，提高了機器人的遠端監控和遠端控制能力，使其能夠進行遠端系統管理。總體而言，COVID-19 大流行凸顯了製藥機器人在醫療緊急情況中的重要性，同時加速了它們與製藥業務的融合，並為疫情後製藥業的進一步自動化和創新鋪平了道路。

預計自動分配系統產業將在預測期內成為最大的產業

在預測期內，自動分配系統領域佔據最大的市場佔有率。這些系統旨在自動精確檢測和分配液體、粉末或其他藥物成分，從而大大減少人為錯誤和污染問題的可能性。此外，自動分配系統具有很強的適應性，可用於各種製藥過程，包括藥品製造和分配藥房中的配製、填充和分配。

預計藥物研發領域在預測期內年複合成長率最高

預計藥物研發領域在預測期內將出現最高的年複合成長率。自動化和機器人技術正在改變藥物研發過程，使其更有效率、準確且具有成本效益。製藥機器人的引入極大地加速了高通量篩選，這是藥物研發的關鍵步驟，可以針對特定生物標的快速測試數千種化合物。此外，這些機器人提供卓越的準確性和一致性，降低人為錯誤和污染的風險，同時保持結果的可靠性。

佔比最大的地區：

由於訓練有素的勞動力、先進的技術基礎設施以及政府為促進製藥業自動化和機器人技術而採取的支援措施的擴大，亞太地區在預測期內佔據了最大的比例。因此，該地區製藥機器人的普及顯著較高，隨著該國製藥公司數量的增加，這一數字預計在不久的將來還會增加。

複合年複合成長率最高的地區：

北美地區預計將實現盈利成長。藥品生產和實驗室流程受到美國食品藥物管理局(FDA) 和加拿大衛生部等法規衛生署制定的高品質和安全要求的約束。此外，這些標準旨在確保藥品的一致性、準確性和完整性。製藥機器人嚴格遵守這些標準，並透過提供精度和自動化來減少錯誤和污染的可能性，從而提高該地區的法規遵循。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球製藥機器人市場：依產品

  • 傳統機器人
    • 關節式機器人
    • 笛卡兒機器人
    • 台達/並聯機器人
  • 協作製藥機器人
  • 自動點膠系統
  • 液體處理機器人
  • 藥品包裝機器人
  • 機器人膠囊充填機
  • 其他產品

第6章 全球製藥機器人市場：依應用分類

  • 藥品檢測
  • 實驗室應用
  • 揀貨和包裝
  • 配藥
  • 藥物研發
  • 庫存控制
  • 藥房自動化
  • 其他用途

第7章 全球製藥機器人市場：依最終用戶分類

  • 調查
  • 製藥公司
  • 藥品研發 (R&D) 設施
  • 臨床實驗室
  • 醫院及醫療機構
  • 生技公司
  • 其他最終用戶

第8章 全球製藥機器人市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • ABB Ltd.
  • Denso Corporation
  • Durr AG
  • Epson Robots
  • FANUC Corporation
  • Kawasaki Heavy Industries Ltd.
  • KUKA AG
  • Marchesini Group
  • Omron Corporation
  • Schaeffler Group
  • Seiko Epson Corporation
  • Staubli International AG
  • Thermo Fisher Scientific Inc.
  • Universal Robots
Product Code: SMRC24327

According to Stratistics MRC, the Global Pharmaceutical Robots Market is accounted for $204.25 million in 2023 and is expected to reach $549.96 million by 2030 growing at a CAGR of 15.2% during the forecast period. The pharmaceutical robot market is a subset of the healthcare and pharmaceutical industries that focuses on the use of robotic technology and automation in a variety of pharmaceutical processes and applications. These specialist robots are designed to perform things like medicine manufacture, drug discovery, sample handling, laboratory automation, and packing. Pharmaceutical robots provide precision, consistency, and efficiency, lowering the risk of human mistakes and contamination and thereby improving pharmaceutical product quality and safety.

According to the data published by CNBC, in June 2020, the cumulative unemployment rate in the U.S. decreased from 14.7% in April 2020 to 13.3% in May 2020, whereas 30% of manufacturers stated that they are seeking to hire new employees during the COVID-19 pandemic as the overall employment rate in the manufacturing sector is facing a sharp contraction, declining at a rate of 19.1% from January 2020 to April 2020.

Market Dynamics:

Driver:

Rising need for sterile environments

Sterile conditions are essential in pharmaceutical manufacturing, particularly in the creation of biologics, to prevent contamination and ensure drug safety and efficacy. Pharmaceutical robots are specifically built to function in cleanroom environments and under aseptic circumstances, making them an invaluable asset in achieving high sterility criteria. The demand for pharmaceutical robots that can function in sterile conditions is increasing as the pharmaceutical industry focuses more on biopharmaceuticals and aseptic processing. These robots not only increase the quality and safety of pharmaceutical products, but they also contribute to the optimization of sterile manufacturing processes, resulting in a key driver in the growth of the pharmaceutical robotics market.

Restraint:

High initial costs

The purchase of the robots themselves, integration into current pharmaceutical processes, and training of workers to operate and maintain the equipment may all result in significant upfront costs for the acquisition and installation of robotic systems. These expenses can be particularly costly for smaller pharmaceutical businesses, research institutions, and startups with limited resources. Pharmaceutical robot investments frequently involve strict financial planning and justification as organizations assess the potential long-term benefits of enhanced efficiency, accuracy, and production against the immediate cost outlay. However, while the technology might result in long-term cost savings and increased product quality, the initial cost barrier might discourage some firms from embracing robotic automation, especially when alternative, more economical alternatives are available.

Opportunity:

Growth in drug development

The pharmaceutical sector is constantly expanding with increased investments in R&D, particularly in areas such as biotechnology and personalized treatment. Pharmaceutical robots play an important part in this ever-changing landscape by accelerating drug discovery and development processes. Pharmaceutical companies are increasingly turning to robotic automation to speed the drug development pipeline as demand for penetration treatments and therapies grows. The pharmaceutical robot market responds to this demand by providing sophisticated solutions to the industry's desire for faster and more efficient drug development procedures, establishing itself as a driving force in this changing landscape.

Threat:

Risk of technological glitches

Robots are used by pharmaceutical businesses to automate important processes such as drug formulation, sample handling, and laboratory testing. While robotic automation has numerous benefits, it is not immune to technical errors or failures, which can pose severe problems and risks to pharmaceutical operations. Robotic system technical faults can cause errors, disturbances, or even damage to valuable drugs. Because of the intricacy of robotic technology, identifying and resolving problems is a specialized and time-consuming procedure that can result in costly downtime and productivity losses.

COVID-19 Impact:

The epidemic also exposed flaws in global supply chains, creating delays in robotic system acquisition and maintenance. In response, the industry evolved by improving the remote monitoring and teleoperation capabilities of robots, allowing them to be managed remotely. Overall, the COVID-19 pandemic highlighted the critical importance of pharmaceutical robots in healthcare emergencies while also hastening their integration into pharmaceutical operations, creating the path for more automation and innovation in the post-pandemic pharmaceutical landscape.

The automated dispensing systems segment is expected to be the largest during the forecast period

The automated dispensing systems segment commanded the largest market share during the projection period, as these systems are intended to automate the exact measurement and distribution of liquids, powders, or other pharmaceutical ingredients, lowering the margin for human error and contamination concerns significantly. Moreover, automated dispensing systems are adaptable and can be used in a variety of pharmaceutical procedures, including compounding, filling, and dosing in drug production and compounding pharmacies.

The drug discovery segment is expected to have the highest CAGR during the forecast period

Drug Discovery segment is expected to have the highest CAGR during the forecast period. Automation and robotics have transformed the drug discovery process, making it more efficient, precise, and cost-effective. With the incorporation of pharmaceutical robots, high-throughput screening, a vital step in drug discovery, has witnessed significant acceleration, allowing rapid testing of thousands of compounds against specific biological targets. Moreover, these robots provide outstanding accuracy and consistency, decreasing human error and contamination risks while maintaining the reliability of the research results.

Region with largest share:

Due to an expanding trained workforce, advanced technical infrastructure, and supportive government initiatives that promote automation and robotics in the pharmaceutical sector, the Asia-Pacific region held the largest percentage over the forecast period. As a result, the region has a significantly high penetration of pharmaceutical robots, and this number is projected to grow in the near future as the country's pharmaceutical enterprises increase.

Region with highest CAGR:

The North America region is expected to experience profitable growth. Pharmaceutical manufacturing and laboratory processes are governed by high quality and safety requirements set by regulatory authorities such as the United States Food and Drug Administration (FDA) and Health Canada. Additionally, these standards are intended to ensure pharmaceutical product consistency, accuracy, and integrity. Pharmaceutical robots adhere closely to these criteria, providing precision and automation that reduces the chance of errors and contamination, hence improving regulatory compliance in the region.

Key players in the market

Some of the key players in Pharmaceutical Robots market include: ABB Ltd., Denso Corporation, Durr AG, Epson Robots, FANUC Corporation, Kawasaki Heavy Industries Ltd., KUKA AG, Marchesini Group, Omron Corporation, Schaeffler Group, Seiko Epson Corporation, Staubli International AG, Thermo Fisher Scientific Inc. and Universal Robots.

Key Developments:

In September 2023, ABB established a new robotics plant at its existing facility in Auburn Hills, Michigan. The expansion is aimed at elevating its product offerings and services to robotics customers in the U.S., Mexico, and Canada. With the expansion, the company becomes the first global industrial robotics company to invest in and fully commit to the North American robotics-manufacturing footprint.

In January 2023, FANUC America Corporation announced the expansion of its headquarters with the construction of a new facility in Auburn Hills, MI. The new facility was used for product development, manufacturing, engineering, and warehousing.

Products Covered:

  • Traditional Robots
  • Collaborative Pharmaceutical Robots
  • Automated Dispensing Systems
  • Liquid Handling Robots
  • Pharmaceutical Packaging Robots
  • Robotic Capsule Fillers
  • Other Products

Applications Covered:

  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications
  • Picking and Packaging
  • Medication Dispensing
  • Drug Discovery
  • Inventory Management
  • Pharmacy Automation
  • Other Applications

End Users Covered:

  • Research Laboratories
  • Pharmaceutical Companies
  • Pharmaceutical Research and Development (R&D) Facilities
  • Clinical Laboratories
  • Hospitals and Healthcare Institutions
  • Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Robots Market, By Product

  • 5.1 Introduction
  • 5.2 Traditional Robots
    • 5.2.1 Articulated Robots
    • 5.2.2 Cartesian Robots
    • 5.2.3 Delta/Parallel Robots
  • 5.3 Collaborative Pharmaceutical Robots
  • 5.4 Automated Dispensing Systems
  • 5.5 Liquid Handling Robots
  • 5.6 Pharmaceutical Packaging Robots
  • 5.7 Robotic Capsule Fillers
  • 5.8 Other Products

6 Global Pharmaceutical Robots Market, By Application

  • 6.1 Introduction
  • 6.2 Inspection of Pharmaceutical Drugs
  • 6.3 Laboratory Applications
  • 6.4 Picking and Packaging
  • 6.5 Medication Dispensing
  • 6.6 Drug Discovery
  • 6.7 Inventory Management
  • 6.8 Pharmacy Automation
  • 6.9 Other Applications

7 Global Pharmaceutical Robots Market, By End User

  • 7.1 Introduction
  • 7.2 Research Laboratories
  • 7.3 Pharmaceutical Companies
  • 7.4 Pharmaceutical Research and Development (R&D) Facilities
  • 7.5 Clinical Laboratories
  • 7.6 Hospitals and Healthcare Institutions
  • 7.7 Biotechnology Companies
  • 7.8 Other End Users

8 Global Pharmaceutical Robots Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 ABB Ltd.
  • 10.2 Denso Corporation
  • 10.3 Durr AG
  • 10.4 Epson Robots
  • 10.5 FANUC Corporation
  • 10.6 Kawasaki Heavy Industries Ltd.
  • 10.7 KUKA AG
  • 10.8 Marchesini Group
  • 10.9 Omron Corporation
  • 10.10 Schaeffler Group
  • 10.11 Seiko Epson Corporation
  • 10.12 Staubli International AG
  • 10.13 Thermo Fisher Scientific Inc.
  • 10.14 Universal Robots

List of Tables

  • Table 1 Global Pharmaceutical Robots Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Robots Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Robots Market Outlook, By Traditional Robots (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Robots Market Outlook, By Articulated Robots (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Robots Market Outlook, By Cartesian Robots (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Robots Market Outlook, By Delta/Parallel Robots (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Robots Market Outlook, By Collaborative Pharmaceutical Robots (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Robots Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Robots Market Outlook, By Liquid Handling Robots (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Robots Market Outlook, By Pharmaceutical Packaging Robots (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Robots Market Outlook, By Robotic Capsule Fillers (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Robots Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Robots Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Robots Market Outlook, By Inspection of Pharmaceutical Drugs (2021-2030) ($MN)
  • Table 15 Global Pharmaceutical Robots Market Outlook, By Laboratory Applications (2021-2030) ($MN)
  • Table 16 Global Pharmaceutical Robots Market Outlook, By Picking and Packaging (2021-2030) ($MN)
  • Table 17 Global Pharmaceutical Robots Market Outlook, By Medication Dispensing (2021-2030) ($MN)
  • Table 18 Global Pharmaceutical Robots Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 19 Global Pharmaceutical Robots Market Outlook, By Inventory Management (2021-2030) ($MN)
  • Table 20 Global Pharmaceutical Robots Market Outlook, By Pharmacy Automation (2021-2030) ($MN)
  • Table 21 Global Pharmaceutical Robots Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Pharmaceutical Robots Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Pharmaceutical Robots Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 24 Global Pharmaceutical Robots Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 25 Global Pharmaceutical Robots Market Outlook, By Pharmaceutical Research and Development (R&D) Facilities (2021-2030) ($MN)
  • Table 26 Global Pharmaceutical Robots Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 27 Global Pharmaceutical Robots Market Outlook, By Hospitals and Healthcare Institutions (2021-2030) ($MN)
  • Table 28 Global Pharmaceutical Robots Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 29 Global Pharmaceutical Robots Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.